MegatrendsMegatrends: not the usual suspects, but who actually profits.View megatrends →

Sensus Healthcare Stock

Sensus Healthcare, Inc.

SRTSNASDAQMarkt
US$2.77
+0.0% today

Company data

Sector
Healthcare
Industry
Medical - Devices
Country
United States
CEO
Joseph C. Sardano
Employees
60
Market cap
$46 M
IPO
26/07/2016

Sensus Healthcare, Inc. operates as a medical technology enterprise, manufacturing and distributing radiation therapy apparatuses to medical institutions across the globe. The company's portfolio leverages superficial radiation therapy (SRT), a cutting-edge low-energy X-ray methodology. Their product line features the…

Sensus Healthcare stock: price history

16/10/25-16.3 %16/10/26

1D

+0.0%

1W

-6.1%

1M

-9.8%

6M

-38.3%

YTD

-30.4%

1Y

-16.3%

2Y

-59.4%

5Y

-30.6%

10Y

-54.4%

Next earnings date

Next earnings date

05/11/2026 (in 19 days)

Volatility around earnings

~180% stronger price swings than usual

Ask the agents about Sensus Healthcare

Analyst assessment of Sensus Healthcare

PRICE TARGET LOW

US$4.00

CONSENSUS

US$4.75

MEDIAN

US$4.75

PRICE TARGET HIGH

US$5.50

0

STRONG BUY

6

BUY

3

HOLD

0

SELL

0

STRONG SELL

9

TOTAL · Buy

As of: 14/08/2026

ANALYST FIRMRATINGACTIONDATE
Lake StreetBuymaintain14/08/2026
Maxim GroupBuymaintain17/02/2026
HC Wainwright & Co.Buymaintain12/08/2025 (older than 12 months)
Lake StreetBuymaintain08/08/2025 (older than 12 months)
Maxim GroupBuymaintain19/05/2025 (older than 12 months)
HC Wainwright & Co.Buymaintain04/04/2025 (older than 12 months)
Lake StreetBuymaintain11/03/2025 (older than 12 months)
HC Wainwright & Co.Buymaintain10/02/2025 (older than 12 months)

Sensus Healthcare stock metrics

P/E

-2.95

P/B

1.24

EV/EBITDA

-3.32

RETURN ON EQUITY

-23.7%

NET MARGIN

-382.1%

DEBT/EQUITY

0.01

DIVIDEND YIELD

0.0%

AS OF

30/06/2026

Free float & liquidity

FREE FLOAT

81.3%

FLOAT SHARES

13,389,317

AVG. DAILY VOLUME (30D)

21,361

Insider transactions (SEC)

ROLETRANSACTIONSHARESPRICEPLAN TYPEDATE

Sachetta Eric

DirectorPurchase27,3043.54Spontaneous31/08/2026

Sachetta Eric

DirectorPurchase37,5373.44Spontaneous31/08/2026

Sachetta Eric

DirectorPurchase9,7083.29Spontaneous28/08/2026

Sachetta Eric

DirectorPurchase10,9253.18Spontaneous28/08/2026

Sachetta Eric

DirectorPurchase34,6973.25Spontaneous25/08/2026
Page 1 / 2

Institutional holders

FUND / INSTITUTIONSHARESCHANGEAS OF
Pacific Ridge Capital Partners, LLC789,675-6,39730/06/2026
VANGUARD CAPITAL MANAGEMENT LLC660,402+12,17730/06/2026
DIMENSIONAL FUND ADVISORS LP316,121-71,27130/06/2026
Divisadero Street Capital Management, LP278,485-7,59330/06/2026
RENAISSANCE TECHNOLOGIES LLC242,334-9,90030/06/2026
Page 1 / 3

Comparable stocks

Frequently asked questions about Sensus Healthcare stock

What does Sensus Healthcare do?

Sensus Healthcare, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.

The CEO is Joseph C. Sardano, the company employs around 60 people.

The IPO was on 26/07/2016; the stock trades on NASDAQ under the ticker SRTS.

What do analysts say about Sensus Healthcare stock?

9 analysts rate the stock, the consensus is Buy (as of 14/08/2026).

The average price target is US$4.75, ranging from US$4.00 to US$5.50, with a median of US$4.75.

This is an external assessment, not a statement by Market Jury.

When does Sensus Healthcare report next?

The next earnings date is 05/11/2026.

Around past earnings, price swings were roughly 180% stronger than usual.

Does Sensus Healthcare pay a dividend?

No, Sensus Healthcare currently does not pay a dividend.

Which stocks are comparable to Sensus Healthcare?

Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.

How can I get Sensus Healthcare stock analyzed?

Clicking "Analyze stock" lets five strategies assess Sensus Healthcare against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.

Not investment advice. Past performance is not an indicator of future results.